How would you treat a newly metastatic ER+ PR+ HER2+ triple positive breast cancer with diffuse symptomatic disease and severe neuropathy from prior adjuvant paclitaxel?
Answer from: Medical Oncologist at Academic Institution
This is a challenging clinical situation where the medical oncologist has to balance the need to rapidly induce a response to relieve the patient's symptoms and the risk of exacerbating the patient's peripheral neuropathy, which may be irreversible. Because of the latter concern, I would avoid stand...
Comments
Medical Oncologist at Providence Hospital and Medical Centers Would you recommend doxorubicin in combination wit...
Medical Oncologist at NYU Winthrop Hospital Never combine doxorubicin with trastuzumumab.
It ...
Medical Oncologist at Warren Alpert Medical School of Brown University I agree that combining trastuzumab (+/- pertuzumab...
Would you recommend doxorubicin in combination wit...
Never combine doxorubicin with trastuzumumab. It ...
I agree that combining trastuzumab (+/- pertuzumab...